Pfizer Ventures led the immuno-oncology drug developer's latest round, which included existing backer Boehringer Ingelheim Venture Fund.

Impulse Dynamics, the developer of an implant for heart failure treatment, has collected $80.3m from investors including Zoll Medical, Abiomed and Minth Group.

Salesforce Ventures took part in a $75m series D1 round for sales optimisation platform Highspot that carried its overall funding to the $200m mark.

Cisco Investments returned to reinvest in the sales analysis platform developer in a round that almost doubled its overall funding.

The e-commerce credit provider closed a $90m round co-led by the Naver-backed Asia Growth Fund that included Telkomsel Indonesia and Singtel, at a $500m valuation.

Echo Health Ventures added $7.5m to a round that already included GV and Centene, helping the mental health care provider expand it to $67.5m.

Pharmaceutical research provider Tigermed co-led a round sized at nearly $71m for the cancer drug developer, which was spun off from Eddingpharm.

The Amazon and Intact Financial-backed insurance provider is raising $40m to $42m in a round that will include $20m from Benny Binsal.

A subsidiary of Sino-Ocean Group has led a $50m series B round for Manbang-backed aftermarket automotive services provider Jybd.

Cancer and autoimmune disease drug developer Clover Biopharmaceuticals has now raised in excess of $100m altogether, Jinrong Group backing its latest round.